Apr 21, 2026 9:00am EDT NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
Apr 17, 2026 3:37pm EDT NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
Apr 21, 2026 4:30 pm EDT NEXGEL Fourth Quarter 2025 Earnings Call Earnings Webcast Audio 10-K Filing PDF HTML XBRL ZIP HTML
